Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Validea Market Legends ETF VALX Jan 20, 2017 0.26 0.00   
 Valley Financial Corp VYFC Jan 20, 2017 21.36 0.00   
 Valley National Bancorp VLYWW Jan 20, 2017 0.03 0.00   
 Value Line VALU Jan 20, 2017 17.58 +0.06   
 Valueclick Inc VCLK Jan 20, 2017 21.00 0.00   
 Valuevision Media VVTV Jan 20, 2017 6.08 0.00   
 Vanda Pharmaceuticals Inc VNDA Jan 20, 2017 13.25 -2.57   
 VanEck Vectors Biotech ETF BBH Jan 20, 2017 111.52 -0.51   
 VanEck Vectors Generic Drugs ETF GNRX Jan 20, 2017 21.47 -0.19   
 VanEck Vectors Pharmaceutical ETF PPH Jan 20, 2017 51.91 -0.54   
 Vanguard Emerging Markets Gover VWOB Jan 20, 2017 78.20 +0.09   
 Vanguard International Dividend Appreciation ETF VIGI Jan 20, 2017 54.02 +0.02   
 Vanguard International High Dividend Yield ETF VYMI Jan 20, 2017 58.29 +0.43   
 Vanguard Natural Resources LLC VNRBP Jan 20, 2017 3.09 +6.19   
 Vanguard Natural Resources Llc VNR Jan 20, 2017 0.81 +6.58   
 Vanguard Natural Resources LLC VNRCP Jan 20, 2017 3.10 +9.93   
 Vanguard Natural Resources Llc Pfd. Series A VNRAP Jan 20, 2017 3.66 +7.65   
 Vanguard Short-Term Inflation-P VTIP Jan 20, 2017 49.27 +0.12   
 Vanguard Total International Bo BNDX Jan 20, 2017 53.85 -0.13   
 Varonis Systems, Inc. VRNS Jan 20, 2017 29.45 +0.68   
 Vasco Data Security International VDSI Jan 20, 2017 14.95 +1.01   
 Vascular Biogenics Ltd. VBLT Jan 20, 2017 5.05 0.00   
 Vascular Solutions VASC Jan 20, 2017 55.85 0.00   
 VBI Vaccines, Inc. VBIV Jan 20, 2017 3.45 +2.07   
 Vca Antech WOOF Jan 20, 2017 90.75 -0.17   
 Vcg Holding Corp. VCGH Jan 20, 2017 2.24 0.00   
 Veeco Instruments Inc VECO Jan 20, 2017 27.10 -0.18   
 Velocityshares Emerging Asia Dr ASDR Jan 20, 2017 68.90 0.00   
 Velocityshares Emerging Markets EMDR Jan 20, 2017 49.28 0.00   
 Velocityshares Equal Risk Weigh ERW Jan 20, 2017 49.00 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK